BOIRON SA (BOI.PA) Stock Overview
Europe - EPA:BOI - FR0000061129 - Common Stock
BOI.PA Key Statistics, Chart & Performance
The current stock price of BOI.PA is 28 EUR. In the past month the price decreased by -3.95%. In the past year, price decreased by -13.85%.
BOI.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1LLY.MI | ELI LILLY & CO | 51.52 | 678.33B | ||
| LLY.DE | ELI LILLY & CO | 51.52 | 678.23B | ||
| ZEG.DE | ASTRAZENECA PLC | 18.87 | 444.61B | ||
| 1JNJ.MI | JOHNSON & JOHNSON | 18.48 | 397.91B | ||
| JNJ.DE | JOHNSON & JOHNSON | 18.32 | 394.53B | ||
| RHO.DE | ROCHE HOLDING AG-BR | 14.45 | 248.76B | ||
| 1ROG.MI | ROCHE HOLDING AG-GENUSSCHEIN | 13.92 | 239.54B | ||
| 1NOVN.MI | NOVARTIS AG-REG | 15.01 | 218.75B | ||
| NOT.DE | NOVARTIS AG-REG | 14.96 | 218.05B | ||
| 1SAN.MI | SANOFI | 14.49 | 217.12B | ||
| SNW.DE | SANOFI | 14.45 | 216.58B | ||
| SAN.PA | SANOFI | 14.44 | 216.39B |
Related stock screener links
About BOI.PA
Company Profile
Boiron SA engages in the manufacturing and selling homeopathic medicines. The company is headquartered in Rontalon, Auvergne-Rhone-Alpes and currently employs 2,736 full-time employees. The firm develops, manufactures and markets single homeopathic medicines and drugs which are in the form of tablets, syrups, single-dose liquids and ointments. The company also produces medicines based on trace elements, phytotherapy remedies, food supplements, as well as health and beauty care products. In addition, the Company owns a research center, which works for the development of homeopathy within the world of medicine. Boiron SA operates through a number of subsidiaries, which are based in Italy, Spain, Belgium, the Czech Republic, Slovakia, Russia, Romania, Poland, Hungary, the United States, Canada and Brazil, among others.
Company Info
BOIRON SA
2 avenue de l ouest Lyonnais
Rontalon AUVERGNE-RHONE-ALPES FR
Employees: 2788
Phone: 33478456100
BOIRON SA / BOI.PA FAQ
Can you describe the business of BOIRON SA?
Boiron SA engages in the manufacturing and selling homeopathic medicines. The company is headquartered in Rontalon, Auvergne-Rhone-Alpes and currently employs 2,736 full-time employees. The firm develops, manufactures and markets single homeopathic medicines and drugs which are in the form of tablets, syrups, single-dose liquids and ointments. The company also produces medicines based on trace elements, phytotherapy remedies, food supplements, as well as health and beauty care products. In addition, the Company owns a research center, which works for the development of homeopathy within the world of medicine. Boiron SA operates through a number of subsidiaries, which are based in Italy, Spain, Belgium, the Czech Republic, Slovakia, Russia, Romania, Poland, Hungary, the United States, Canada and Brazil, among others.
Can you provide the latest stock price for BOIRON SA?
The current stock price of BOI.PA is 28 EUR. The price increased by 2.94% in the last trading session.
Does BOIRON SA pay dividends?
BOIRON SA (BOI.PA) has a dividend yield of 4.41%. The yearly dividend amount is currently 1.35.
How is the ChartMill rating for BOIRON SA?
BOI.PA has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Can you provide the PE ratio for BOI stock?
The PE ratio for BOIRON SA (BOI.PA) is 25. This is based on the reported non-GAAP earnings per share of 1.12 and the current share price of 28 EUR.
Is BOIRON SA (BOI.PA) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on BOI.PA.
BOI.PA Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to BOI.PA. When comparing the yearly performance of all stocks, BOI.PA turns out to be only a medium performer in the overall market: it outperformed 51.26% of all stocks.
BOI.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to BOI.PA. No worries on liquidiy or solvency for BOI.PA as it has an excellent financial health rating, but there are worries on the profitability.
BOI.PA Financial Highlights
Over the last trailing twelve months BOI.PA reported a non-GAAP Earnings per Share(EPS) of 1.12. The EPS decreased by -18.25% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.84% | ||
| ROA | 3.45% | ||
| ROE | 5.25% | ||
| Debt/Equity | 0.04 |
BOI.PA Forecast & Estimates
For the next year, analysts expect an EPS growth of 5.53% and a revenue growth 2.95% for BOI.PA